Inovio Pharmaceuticals Inc (INO)
10.37
+0.35
(+3.49%)
USD |
NASDAQ |
Apr 23, 16:00
10.60
+0.23
(+2.22%)
After-Hours: 07:50
Inovio Pharmaceuticals Debt to Equity Ratio: 0.1429 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.1429 |
September 30, 2023 | 0.1193 |
June 30, 2023 | 0.0986 |
March 31, 2023 | 0.0823 |
December 31, 2022 | 0.0747 |
September 30, 2022 | 0.0611 |
June 30, 2022 | 0.0555 |
March 31, 2022 | 0.0456 |
December 31, 2021 | 0.0374 |
September 30, 2021 | 0.0319 |
June 30, 2021 | 0.0286 |
March 31, 2021 | 0.0242 |
December 31, 2020 | 0.0405 |
September 30, 2020 | 0.1658 |
June 30, 2020 | 0.4272 |
March 31, 2020 | 0.4153 |
December 31, 2019 | 22.42 |
September 30, 2019 | 2.080 |
June 30, 2019 | 1.170 |
March 31, 2019 | 0.7773 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0242
Minimum
Mar 2021
22.42
Maximum
Dec 2019
1.449
Average
0.0823
Median
Mar 2023
Debt to Equity Ratio Benchmarks
Cerus Corp | 1.516 |
Stereotaxis Inc | 0.00 |
Viemed Healthcare Inc | 0.0621 |
AIM ImmunoTech Inc | 0.00 |
Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 170.95M |
Total Liabilities (Quarterly) | 53.60M |
Shareholders Equity (Quarterly) | 117.35M |
Current Ratio | 3.597 |
Net Debt Paydown Yield | -0.07% |